Calendar Orchestra BioMed Holdings, Inc.

Equities

OBIO

US68572M1062

Market Closed - Nasdaq 04:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
4.95 USD +1.43% Intraday chart for Orchestra BioMed Holdings, Inc. -10.81% -45.78%

Chart calendar Orchestra BioMed Holdings, Inc.

b9c1e3fb1ded9a.TZ3BDonBceMl3rTIseKZs8-B-ljeTviIpthpbcIkPTc.eMmqbeyIM4xqutr_6bvD2Im0ySmaGMzvyKlROacRSw8i65RbyKcL0XSs3w~db3c628cafcc299d65b9c0c42c63221c

Upcoming events on Orchestra BioMed Holdings, Inc.

2024-06-11 10:00 am R&D Day
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)

Past events on Orchestra BioMed Holdings, Inc.

Today Q1 2024 Earnings Release (Projected)
2024-03-27 04:17 pm Q4 2023 Earnings Release
2024-03-14 11:15 am Barclays Global Healthcare Conference
2024-03-12 03:20 pm Oppenheimer Healthcare MedTech & Services Conference
2023-12-05 Mizuho Med Devices Summit
2023-11-29 01:00 pm Piper Sandler Healthcare Conference
2023-11-14 07:00 am Jefferies London Healthcare Conference
2023-11-13 04:21 pm Q3 2023 Earnings Release
2023-09-19 08:30 am Business Update Call
2023-08-10 04:34 pm Q2 2023 Earnings Release
2023-06-08 02:30 pm Jefferies Global Healthcare Conference
2023-05-12 09:15 am Q1 2023 Earnings Release
2023-03-14 08:30 am Barclays Global Healthcare Conference
2023-03-13 04:00 pm Oppenheimer Healthcare Conference
2023-02-26 02:00 pm Cardiovascular Research Technologies Meeting - Virtue® Sirolimus AngioInfusion Balloon (SAB) Overvie
2023-02-26 08:00 am Cardiovascular Research Technologies Meeting - Cardiac Neuromodulation Therapy for Medically Refract
2023-01-23 Extraordinary Shareholders Meeting - M&A Vote

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


3,53
3,74
-5.45%
2,76
3,53
-21.79%

3,31

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-51,2
-52,0
1.5%

-63,0

EBIT
Million USD
Released
Forecast
Spread
0,00


-32,7
-32,8
0.36%
-51,5
-53,1
2.99%

-62,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-33,6
-32,0
-4.97%
-49,1
-50,8
3.25%

-58,6

Net income
Million USD
Released
Forecast
Spread
-23,0


-35,6
-33,5
-6.48%
-49,1
-50,8
3.25%

-58,6

EPS
USD
Released
Forecast
Spread
-10,9


-14,6
-9,61
-51.93%
-1,48
-1,50
1%

-1,57

Announcement Date22/11/2224/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
1,10
1,18
-6.53%
1,16
0,68
71.18%
0,92
0,71
29.6%
0,42
0,90
-53.18%
0,26
0,99
-73.66%

0,58


0,60


1,09


1,10


0,68

EBITDA
Million USD
Released
Forecast
Spread












-12,4
-13,0
4.55%

-14,3


-15,3


-16,8


-16,0




EBIT
Million USD
Released
Forecast
Spread
-9,83
-9,68
-1.57%
-11,5
-9,36
-23.4%
-13,0
-13,1
1.46%
-14,5
-13,4
-8.78%
-12,5
-14,1
11.38%

-15,0


-15,5


-16,0


-15,5


-14,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,75
-8,18
-19.25%
-10,9
-7,36
-48.72%
-12,0
-12,4
3.23%
-13,3
-12,7
-5.25%
-12,8
-14,5
11.39%

-15,0


-15,0


-14,5


-14,2


-14,2

Net income
Million USD
Released
Forecast
Spread
-9,75
-8,18
-19.25%
-10,9
-7,36
-48.72%
-12,0
-12,4
3.23%
-13,3
-12,7
-5.25%
-12,8
-14,5
11.39%

-15,0


-15,0


-14,5


-14,2


-14,2

EPS
USD
Released
Forecast
Spread
-3,88
-3,14
-23.57%
-0,40
-0,29
-40.35%
-0,35
-0,42
15.66%
-0,38
-0,39
2.56%
-0,37
-0,41
9.76%

-0,41


-0,40


-0,38


-0,38


-0,40

Announcement Date24/03/2312/05/2310/08/2313/11/2327/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. OBIO Stock
  4. Calendar Orchestra BioMed Holdings, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW